Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study

1. Stenlöf, K.
2. Cefalu, W.T.
3. Kim, K.-A.
4. Jodar, E.
5. Alba, M.
6. Edwards, R.
7. Tong, C.
8. Canovatchel, W.
9. Meininger, G.